Emerging evidence on oral contraceptives and arterial disease

被引:13
作者
Heinemann, LAJ [1 ]
机构
[1] Ctr Epidemiol & Hlth Res, Berlin, Germany
关键词
oral contraceptives; risk factors; venous thromboembolism; stroke; myocardial infarction;
D O I
10.1016/S0010-7824(00)00146-3
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
A number of case-control studies published in recent years have shown an apparent increase in the risk of venous thromboembolism (VTE) associated with the use of third-generation oral contraceptives (OCs) compared with second-generation OCs. However, it is thought that these studies were subject to a number of biases that would have increased the risk estimates for third-generation OCs while lowering those for second-generation preparations. Data on the risk of ischemic stroke and myocardial infarction (MI) show no such difference between generations of OCs, with a statistically significant reduction in the risk of acute MI from first- to third-generation in one major study. Available results indicate that there is no significant increase in the risk of ischemic stroke or acute MI associated with the use of low-dose estrogen OCs in young women who are properly screened before use, and who have no pre-existing cardiovascular risk factors, such as smoking and hypertension, for these conditions. These findings should be taken into account when interpreting the results of studies on the risk of VTE in women taking combined OCs. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:29S / 36S
页数:8
相关论文
共 50 条
[41]   Blood coagulation and oral contraceptives -: A critical review [J].
Winkler, UH .
CONTRACEPTION, 1998, 57 (03) :203-209
[42]   Oral contraceptives and cardiovascular outcomes: cause or bias? [J].
Spitzer, WO .
CONTRACEPTION, 2000, 62 (02) :3S-9S
[43]   ORAL-CONTRACEPTIVES AND MYOCARDIAL-INFARCTION [J].
THORNEYCROFT, IH .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (04) :1393-1397
[44]   Do oral contraceptives act as mood stabilizers? Evidence of positive affect stabilization [J].
Jarva, J. A. ;
Oinonen, K. A. .
ARCHIVES OF WOMENS MENTAL HEALTH, 2007, 10 (05) :225-234
[45]   ORAL-CONTRACEPTIVES, INSULIN RESISTANCE AND ISCHEMIC VASCULAR-DISEASE [J].
ESCHWEGE, E ;
FONTBONNE, A ;
SIMON, D ;
THIBULT, N ;
BALKAU, B ;
SAINTPAUL, M ;
GARNIER, P ;
SENAN, C ;
PAPOZ, L .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1990, 31 (03) :263-269
[46]   Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives [J].
Sidney, S ;
Petitti, DB ;
Soff, GA ;
Cundiff, DL ;
Tolan, KK ;
Quesenberry, CP .
CONTRACEPTION, 2004, 70 (01) :3-10
[47]   Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptives [J].
Schwingl, PJ ;
Shelton, J .
CONTRACEPTION, 1997, 55 (03) :125-129
[48]   Effects on hemostatic variables of desogestrel- and gestodene-containing oral contraceptives in comparison with levonorgestrel-containing oral contraceptives: A review [J].
Winkler, UH .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 179 (03) :S51-S61
[49]   Venous thromboembolism, oral contraceptives and high prothrombin levels [J].
Legnani, C ;
Cosmi, B ;
Valdrè, L ;
Boggian, O ;
Bernardi, F ;
Coccheri, S ;
Palareti, G .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (01) :112-117
[50]   Smoking and use of oral contraceptives: Impact on thrombotic diseases [J].
Lidegaard, O .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 180 (06) :S357-S363